Institute News
Most Popular
The Latest MacTel Research: What does it mean for patients?
Scientists at the Lowy Medical Research Institute and their collaborators recently published an article describing a role for serine and toxic lipids in macular telangiectasia type 2. The article, “Serine and Lipid Metabolism in Macular Disease and...
Free community webinar about MacTel
November 14, 2024 The following information was sent out via email to people who registered in the LMRI Contact Database. Neurotech has partnered with Prevent Blindness to sponsor an online event with a focus on MacTel Type 2. This free webinar...
What To Expect in a MacTel Imaging Exam
April 29, 2024 The following information was sent out via email to people who registered in the LMRI Contact Database. This post will explain some (but not all) of the imaging exams that your eye doctor may perform during a screening or follow up...
Neurotech Provides Update on BLA for NT-501 as a Treatment for Macular Telangiectasia Type 2 (MacTel)
LMRI would like to share the following press release from Neurotech Pharmaceuticals about the BLA for NT-501 as a treatement for MacTel: Cumberland, R.I., November 8, 2024 (BUSINESS WIRE) – Neurotech Pharmaceuticals, Inc., an innovator in sustained...
MacTel Project 2021 Update
LOWY MEDICAL RESEARCH INSTITUTE - LMRI This past year has surely been an interesting and challenging one. We hope that you and your family, friends, neighbors, and coworkers were able to weather the events safely. Despite the many challenges prese...